Real-world comparative effectiveness of rivaroxaban versus heparin and phenprocoumon for the treatment and secondary prevention of venous thromboembolism (RECENT)

30/06/2020
23/04/2024
EU PAS number:
EUPAS36102
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

21456_EU PAS_study protocol

English (2.71 MB - PDF) View document
Study results
Study results

21456_EU PAS Register_Abstract

English (442.55 KB - PDF) View document
Study report
Study report

OS_Report_21456_RECENT_FINAL_redacted

English (3.7 MB - PDF) View document
Other information